🇺🇸 FDA
Pipeline program

Piclidenoson

PICLILOWE

Phase 2 small_molecule active

Quick answer

Piclidenoson for Lowe Syndrome is a Phase 2 program (small_molecule) at Can-Fite BioPharma with 1 ClinicalTrials.gov record(s).

Program details

Company
Can-Fite BioPharma
Indication
Lowe Syndrome
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials